|
1
|
Duncan TJ, Al-Attar A, Rolland P, Harper
S, Spendlove I and Durrant LG: Cytoplasmic p27 expression is an
independent prognostic factor in ovarian cancer. Int J Gynecol
Pathol. 29:8–18. 2010. View Article : Google Scholar
|
|
2
|
Sgambato A, Camerini A, Genovese G, De
Luca F, Viacava P, Migaldi M, Boninsegna A, Cecchi M, Sepich CA,
Rossi G, et al: Loss of nuclear p27(Kip1) and
α-dystroglycan is a frequent event and is a strong predictor of
poor outcome in renal cell carcinoma. Cancer Sci. 101:2080–2086.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Tomoda K, Kubota Y and Kato J: Degradation
of the cyclin-dependent-kinase inhibitor p27Kip1 is instigated by
Jab1. Nature. 398:160–165. 1999. View
Article : Google Scholar : PubMed/NCBI
|
|
4
|
Smitherman M, Lee K, Swanger J, Kapur R
and Clurman BE: Characterization and targeted disruption of murine
Nup50, a p27(Kip1)-interacting component of the nuclear pore
complex. Mol Cell Biol. 20:5631–5642. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Connor MK, Kotchetkov R, Cariou S, Resch
A, Lupetti R, Beniston RG, Melchior F, Hengst L and Slingerland JM:
CRM1/Ran-mediated nuclear export of p27(Kip1) involves a nuclear
export signal and links p27 export and proteolysis. Mol Biol Cell.
14:201–213. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ganeshan D, Moron FE and Szklaruk J:
Extrahepatic biliary cancer: new staging classification. World J
Radiol. 4:345–352. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Jang JY, Kim SW, Park DJ, Ahn YJ, Yoon YS,
Choi MG, Suh KS, Lee KU and Park YH: Actual long-term outcome of
extrahepatic bile duct cancer after surgical resection. Ann Surg.
241:77–84. 2005.
|
|
8
|
Wang Y, Wang Y, Xiang J, Ji F, Deng Y,
Tang C, Yang S, Xi Q, Liu R and Di W: Knockdown of CRM1 inhibits
the nuclear export of p27(Kip1) phosphorylated at serine 10 and
plays a role in the pathogenesis of epithelial ovarian cancer.
Cancer Lett. 343:6–13. 2014. View Article : Google Scholar
|
|
9
|
Pan Y, Zhang Q, Tian L, Wang X, Fan X,
Zhang H, Claret FX and Yang H: Jab1/CSN5 negatively regulates p27
and plays a role in the pathogenesis of nasopharyngeal carcinoma.
Cancer Res. 72:1890–1900. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Dai L, Liu Y, Liu J, Wen X, Xu Z, Wang Z,
Sun H, Tang S, Maguire AR, Quan J, et al: A novel
cyclinE/cyclinA-CDK inhibitor targets p27(Kip1) degradation, cell
cycle progression and cell survival: implications in cancer
therapy. Cancer Lett. 333:103–112. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ciaparrone M, Yamamoto H, Yao Y, Sgambato
A, Cattoretti G, Tomita N, Monden T, Rotterdam H and Weinstein IB:
Localization and expression of p27KIP1 in multistage colorectal
carcinogenesis. Cancer Res. 58:114–122. 1998.PubMed/NCBI
|
|
12
|
Masciullo V, Ferrandina G, Pucci B,
Fanfani F, Lovergine S, Palazzo J, Zannoni G, Mancuso S, Scambia G
and Giordano A: p27Kip1 expression is associated with clinical
outcome in advanced epithelial ovarian cancer: multivariate
analysis. Clin Cancer Res. 6:4816–4822. 2000.
|
|
13
|
Ibañez IL, Bracalente C, Notcovich C,
Tropper I, Molinari BL, Policastro LL and Durán H: Phosphorylation
and subcellular localization of p27Kip1 regulated by hydrogen
peroxide modulation in cancer cells. PLoS One. 7:e445022012.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Tsvetkov LM, Yeh KH, Lee SJ, Sun H and
Zhang H: p27(Kip1) ubiquitination and degradation is regulated by
the SCF(Skp2) complex through phosphorylated Thr187 in p27. Curr
Biol. 9:661–664. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kazi A, Carie A, Blaskovich MA, Bucher C,
Thai V, Moulder S, Peng H, Carrico D, Pusateri E, Pledger WJ, et
al: Blockade of protein geranylgeranylation inhibits Cdk2-dependent
p27Kip1 phosphorylation on Thr187 and accumulates p27Kip1 in the
nucleus: implications for breast cancer therapy. Mol Cell Biol.
29:2254–2263. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Luo J, Chen YJ, Wang WY and Zou SQ: Effect
of mutant p27(kipl) gene on human cholangiocarcinoma cell line,
QBC(939). World J Gastroenterol. 14:5344–5348. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kamura T, Hara T, Matsumoto M, Ishida N,
Okumura F, Hatakeyama S, Yoshida M, Nakayama K and Nakayama KI:
Cytoplasmic ubiquitin ligase KPC regulates proteolysis of p27(Kip1)
at G1 phase. Nat Cell Biol. 6:1229–1235. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kotoshiba S and Nakayama K: The
degradation of p27 and cancer. Nihon Rinsho. 63:2047–2056. 2005.In
Japanese. PubMed/NCBI
|
|
19
|
Lee JG, Song JS, Smith RE and Kay EP:
Human corneal endothelial cells employ phosphorylation of p27(Kip1)
at both Ser10 and Thr187 sites for FGF-2-mediated cell
proliferation via PI3-kinase. Invest Ophthalmol Vis Sci.
52:8216–8223. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Rodier G, Montagnoli A, Di Marcotullio L,
Coulombe P, Draetta GF, Pagano M and Meloche S: p27 cytoplasmic
localization is regulated by phosphorylation on Ser10 and is not a
prerequisite for its proteolysis. EMBO J. 20:6672–6682. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Shen A, Wang Y, Zhao Y, Zou L, Sun L and
Cheng C: Expression of CRM1 in human gliomas and its significance
in p27 expression and clinical prognosis. Neurosurgery. 65:153–160.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
He W, Wang B, Zhuang Y, Shao D, Sun K and
Chen J: Berberine inhibits growth and induces G1 arrest and
apoptosis in human cholangiocarcinoma QBC939 cells. J Pharmacol
Sci. 119:341–348. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Huether A, Höpfner M, Baradari V, Schuppan
D and Scherübl H: Sorafenib alone or as combination therapy for
growth control of cholangiocarcinoma. Biochem Pharmacol.
73:1308–1317. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kotake Y, Nakayama K, Ishida N and
Nakayama KI: Role of serine 10 phosphorylation in p27 stabilization
revealed by analysis of p27 knock-in mice harboring a serine 10
mutation. J Biol Chem. 280:1095–1102. 2005. View Article : Google Scholar
|
|
25
|
Nadeem L, Brkic J, Chen YF, Bui T, Munir S
and Peng C: Cytoplasmic mislocalization of p27 and CDK2 mediates
the anti-migratory and anti-proliferative effects of Nodal in human
trophoblast cells. J Cell Sci. 126:445–453. 2013. View Article : Google Scholar
|
|
26
|
Shiraso S, Katayose Y, Yamamoto K, Mizuma
M, Yabuuchi S, Oda A, Rikiyama T, Onogawa T, Yoshida H, Hayashi H,
et al: Overexpression of adenovirus-mediated p27Kip1
lacking the Jab1-binding region enhances cytotoxicity and inhibits
xenografted human cholangiocarcinoma growth. Anticancer Res.
29:2015–2024. 2009.PubMed/NCBI
|
